TLDR Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.
This edition of the news section provided Cancer readers with insights into various topics, including the benefits of oophorectomy in reducing ovarian cancer risk for women with BRCA mutations, emphasizing the importance of counseling and support for these patients. It also highlighted a study confirming that finasteride reduced prostate cancer risk without increasing mortality risk. Additionally, it noted a significant increase in prophylactic mastectomy rates in the United States and discussed a new analysis aimed at predicting DCIS recurrence.
11 citations
,
February 2004 in “Clinical and Experimental Ophthalmology” Taking Propecia might lead to the development of cataracts.
June 2024 in “Georgetown medical review” Finasteride treats hair loss but may cause low libido, erectile issues, and depression.
June 2017 in “Reactions Weekly” Finasteride (Propecia) may cause depression and suicidal thoughts; stop use and inform a healthcare professional if symptoms develop.
3 citations
,
June 2004 in “Annales De Dermatologie Et De Venereologie” Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.
Finasteride is popular for treating male hair loss but may increase the risk of serious prostate cancer and has other potential side effects.
2 citations
,
January 2003 in “Journal of Clinical Dermatology” 1 mg finasteride can cause reversible painful breast enlargement in men.
